Skip to main content
$57.20 -$0.27 (-0.5%)

12:38 PM EDT on 09/17/21

Emergent BioSolutions, Inc. (NYSE:EBS)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.

Current Price $57.20 Mkt Cap $3.1B
Open $57.35 P/E Ratio 10.24
Prev. Close $57.47 Div. (Yield) $0.00 (0.0%)
Daily Range $56.50 - $57.65 Volume 154,068
52-Wk Range $55.07 - $127.20 Avg. Daily Vol. 392,491

Caps

How do you think NYSE:EBS will perform against the market?

Add Stock to CAPS Watchlist

All Players

509 Outperform
17 Underperform
 

All-Star Players

82 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:EBS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

JOhrberg (74.56)
Submitted October 13, 2020

Taking advantage of a pullback in price. Thinking they will be a valuable player in vaccine production.

gopyerk (72.33)
Submitted March 08, 2013

Projecting earnings declines for 3 of 4 quarters coming up. I think in the long term there are some things to like here, but for the short run, when considering the negative growth picture I just don't like this

NYSE:EBS VS S&P 500 (SPY)

Fools bullish on NYSE:EBS are also bullish on:

Fools bearish on NYSE:EBS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EBS.

Recs

0
Member Avatar Car12703 (64.83) Submitted: 6/22/2021 12:01:42 PM : Outperform Start Price: $58.94 NYSE:EBS Score: -7.88

From Fidelity June 2021:
Revenue Growth (Last 5 Years) = 24.4%
Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 78.2%
Price/Sales (TTM) = 1.9

Recs

0
Member Avatar Etirado (25.14) Submitted: 2/26/2021 8:48:43 AM : Outperform Start Price: $97.50 NYSE:EBS Score: -56.55

Screener Pick 2-26-21

Recs

0
Member Avatar hriket (98.02) Submitted: 2/23/2021 11:26:23 AM : Outperform Start Price: $91.55 NYSE:EBS Score: -52.63

EBS's current infrastructure will play a big role in COVID vaccine manufacturing

Leaderboard

Find the members with the highest scoring picks in EBS.

Score Leader

Sandman333

Sandman333 (54.45) Score: +897.54

I picked this stock on the principle that it had sound financials, was picked outperform by many CAPS All-Stars, and had recently tanked for no apparent reason.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Sandman333 54.45 11/15/2007 Outperform 5Y $4.70 +1,115.96% +217.86% +898.10 0 Comment
stewartsjunk 71.97 12/18/2007 Outperform 5Y $4.81 +1,088.15% +217.69% +870.46 0 Comment
DBerriman < 20 11/27/2007 Outperform 3W $4.79 +1,093.11% +226.41% +866.71 1 Comment
orsibros 70.72 11/28/2007 Outperform 5Y $5.00 +1,043.00% +221.91% +821.09 0 Comment
jessba15 34.95 11/28/2007 Outperform 1Y $5.00 +1,043.00% +221.91% +821.09 0 Comment
TRIPODTODD 28.88 12/4/2007 Outperform 3W $5.17 +1,005.42% +216.20% +789.21 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. caslonsvcs 97.66 12/27/2007 10/17/2019 Outperform 3M $5.25 +988.57% +211.11% +777.46 0 Comment
tenmiles 27.96 11/14/2007 Outperform 3Y $5.71 +900.88% +212.28% +688.60 3 Comments
no12call < 20 1/7/2008 Outperform 3M $6.60 +765.91% +225.39% +540.52 0 Comment
racerz58 46.56 1/7/2008 Outperform 3M $6.60 +765.91% +226.10% +539.81 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for EBS.